维拉德美制药

最新新闻

• 评级变动
  Analysts Are Bullish on Top NA Stocks: Veradermics, Incorporated (MANE), Bicara Therapeutics Inc. (BCAX)
  TipRanks · 2026/8/12
• 评级变动
  Jefferies Maintains Veradermics(MANE.US) With Buy Rating, Maintains Target Price $182
  \u5e02\u573a\u8d44\u8baf · 2026/7/16
• 评级变动
  Needham Maintains Veradermics(MANE.US) With Buy Rating, Maintains Target Price $164
  \u5e02\u573a\u8d44\u8baf · 2026/8/13
• 评级变动
  B. Riley Analyst Initiates Coverage of Veradermics Stock (MANE) With a Buy Rating
  TipRanks · 2026/7/16
• 评级变动
  Jefferies Maintains Veradermics(MANE.US) With Buy Rating, Raises Target Price to $138
  \u5e02\u573a\u8d44\u8baf · 2026/5/14
• 评级变动
  LifeSci Capital Initiates Veradermics(MANE.US) With Buy Rating, Announces Target Price $135
  \u5e02\u573a\u8d44\u8baf · 2026/6/16
• 评级变动
  Jefferies Maintains Veradermics(MANE.US) With Buy Rating, Maintains Target Price $138
  \u5e02\u573a\u8d44\u8baf · 2026/6/16
• Citi Maintains Veradermics(MANE.US) With Buy Rating, Maintains Target Price $160
  \u5e02\u573a\u8d44\u8baf · 2026/9/15
• 评级变动
  Jefferies Maintains Veradermics(MANE.US) With Buy Rating, Raises Target Price to $182
  \u5e02\u573a\u8d44\u8baf · 2026/7/7
• 评级变动
  Analysts Conflicted on These NA Names: HeartFlow, Inc. (HTFL), Phoenix Education Partners, Inc. (PXED) and Veradermics, Incorporated (MANE)
  TipRanks · 2026/7/15
• 评级变动
  Citi Maintains Veradermics(MANE.US) With Buy Rating, Raises Target Price to $135
  \u5e02\u573a\u8d44\u8baf · 2026/5/18
• Veradermics(MANE.US) Officer Sells US$7.28 Million in Common Stock
  \u5e02\u573a\u8d44\u8baf · 2026/8/19
• LifeSci Capital Maintains Veradermics(MANE.US) With Buy Rating, Maintains Target Price $170
  \u5e02\u573a\u8d44\u8baf · 2026/8/12
• 评级变动
  Needham Initiates Veradermics(MANE.US) With Buy Rating, Announces Target Price $136
  \u5e02\u573a\u8d44\u8baf · 2026/6/2
• LifeSci Capital Maintains Veradermics(MANE.US) With Buy Rating, Raises Target Price to $170
  \u5e02\u573a\u8d44\u8baf · 2026/7/15
• Veradermics(MANE.US) Officer Sells US$4.69 Million in Common Stock
  \u5e02\u573a\u8d44\u8baf · 2026/8/19
• 评级变动
  Needham Maintains Veradermics(MANE.US) With Buy Rating, Raises Target Price to $164
  \u5e02\u573a\u8d44\u8baf · 2026/7/15
• 评级变动
  Citi Maintains Veradermics(MANE.US) With Buy Rating, Raises Target Price to $160
  \u5e02\u573a\u8d44\u8baf · 2026/7/16
• 评级变动
  Citi Maintains Veradermics(MANE.US) With Buy Rating, Maintains Target Price $135
  \u5e02\u573a\u8d44\u8baf · 2026/6/22
• 评级变动
  B. Riley Securities Initiates Veradermics(MANE.US) With Buy Rating, Announces Target Price $170
  \u5e02\u573a\u8d44\u8baf · 2026/7/15

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。